10 May 2017
The EFRO-funded project to build an accelerator for cell therapy, a joint initiative from POM Antwerp, the University of Antwerp and the Antwerp University Hospital, is approved.
25 September 2018
The construction of the building for the GMP-certified lab infrastructure at the Science Park of the University of Antwerp in Niel, Belgium, started.
1 February 2019
The construction of the building is completed and the installation of the GMP-compliant lab infrastructure inside the building started.
17 April 2019
Anicells is founded as a spin-off company of the University of Antwerp and the Antwerp University Hospital, with headquarters in Niel, Belgium.
6 May 2019
The GMP-compliant lab infrastructure is ready for certification.
6 May 2020
Anicells obtains manufacturing authorisation for GMP-compliant production of cell therapeutic products from the Belgian competent authority, FAMHP.